solriamfetol Sunosi
Selected indexed studies
- Solriamfetol (Sunosi) for excessive daytime sleepiness. (Med Lett Drugs Ther, 2019) [PMID:31581157]
- Solriamfetol. (, 2012) [PMID:34516056]
- Solriamfetol. (, 2006) [PMID:31038853]
_Worker-drafted node — pending editorial review._
Connections
solriamfetol Sunosi is a side effect of
Sources
- Solriamfetol. (2012) pubmed
- Solriamfetol. (2006) pubmed
- Solriamfetol for the Management of Excessive Daytime Sleepiness. (2022) pubmed
- Solriamfetol for Attention-Deficit/Hyperactivity Disorder in Adults: A Double-Blind Placebo-Controlled Pilot Study. (2023) pubmed
- Solriamfetol (Sunosi) for excessive daytime sleepiness. (2019) pubmed
- Idiopathic Hypersomnia and Other Hypersomnia Syndromes. (2021) pubmed
- Solriamfetol: First Global Approval. (2019) pubmed
- European guideline and expert statements on the management of narcolepsy in adults and children. (2021) pubmed
- Solriamfetol: A Review in Excessive Daytime Sleepiness Associated with Narcolepsy and Obstructive Sleep Apnoea. (2023) pubmed
- Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine clinical practice guideline. (2021) pubmed